SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019670
Filing Date
2023-05-09
Accepted
2023-05-09 16:11:45
Documents
67
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pstx-20230331.htm   iXBRL 10-Q 2468932
2 EX-10.1 pstx-ex10_1.htm EX-10 62733
3 EX-31.1 pstx-ex31_1.htm EX-31 16633
4 EX-31.2 pstx-ex31_2.htm EX-31 16632
5 EX-32.1 pstx-ex32_1.htm EX-32 11245
6 EX-32.2 pstx-ex32_2.htm EX-32 11269
7 GRAPHIC img78622461_0.jpg GRAPHIC 767267
  Complete submission text file 0000950170-23-019670.txt   9532175

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pstx-20230331_def.xml EX-101.DEF 189974
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pstx-20230331.xsd EX-101.SCH 52920
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pstx-20230331_pre.xml EX-101.PRE 329678
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pstx-20230331_lab.xml EX-101.LAB 465464
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pstx-20230331_cal.xml EX-101.CAL 44496
61 EXTRACTED XBRL INSTANCE DOCUMENT pstx-20230331_htm.xml XML 1416248
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39376 | Film No.: 23902111
SIC: 2836 Biological Products, (No Diagnostic Substances)